DUBLIN--(BUSINESS WIRE)--The "Global Orphan Drugs Market: Industry Analysis & Outlook (2018-2022)" report has been added to ResearchAndMarkets.com's offering.
Global Orphan Drugs Market: Industry Analysis & Outlook (2018-2022) provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the US, Europe and Asia along with the global market.
Orphan drug market is likely to witness a growth in future with increasing development and approvals of ultra-rare drugs and rising developments in drugs for rare blood disease. The US and Europe are the major contributors to the global orphan drugs market supported by increased numbers of orphan drug designations. Asia is likely to experience further growth with increasing orphan designations in Japan and improving healthcare facilities.
The global orphan drugs market is expected to grow in future due to prolonged orphan drug market exclusivity, increasing sales of prescription drugs, attractive orphan drug policies, rising healthcare expenditure, improving economies and increasing prevalence of chronic diseases.
Key trends & development of this market include rise in orphan drug approvals, accelerating pipeline sales of orphan drugs, development of drug therapies and rising scope in gene therapy. However, there are some factors which can hinder growth of the market including high costs of drugs, increased competition from generic industry, insufficient disease information & research participants and deficiency of diagnostic systems and trained professionals.
The report profiles key players of the market including Roche holding AF, Novartis International AG, Bristol-Myers Squibb and Celgene Corporation.
Key Topics Covered:
1. Overview
2. Global Orphan Drugs Market
3. Regional Market Analysis
4. Market Dynamics
5. Competitive Landscape
6. Company Profiles
- Novartis International AG
- Roche Holding AG
- Bristol-Myers Squibb
- Celgene Corporation
For more information about this report visit https://www.researchandmarkets.com/research/qcwnw3/global_orphan?w=4
